Logo image
Glyoxalase 1 increases anxiety by reducing GABA(A) receptor agonist methylglyoxal
Journal article   Open access   Peer reviewed

Glyoxalase 1 increases anxiety by reducing GABA(A) receptor agonist methylglyoxal

Margaret G Distler, Leigh D Plant, Greta Sokoloff, Andrew J Hawk, Ivy Aneas, Gerald E Wuenschell, John Termini, Stephen C Meredith, Marcelo A Nobrega and Abraham A Palmer
The Journal of clinical investigation, Vol.122(6), pp.2306-2315
06/01/2012
DOI: 10.1172/JCI61319
PMCID: PMC3366407
PMID: 22585572
url
https://doi.org/10.1172/JCI61319View
Published (Version of record) Open Access

Abstract

Glyoxalase 1 (Glo1) expression has previously been associated with anxiety in mice; however, its role in anxiety is controversial, and the underlying mechanism is unknown. Here, we demonstrate that GLO1 increases anxiety by reducing levels of methylglyoxal (MG), a GABA(A) receptor agonist. Mice overexpressing Glo1 on a Tg bacterial artificial chromosome displayed increased anxiety-like behavior and reduced brain MG concentrations. Treatment with low doses of MG reduced anxiety-like behavior, while higher doses caused locomotor depression, ataxia, and hypothermia, which are characteristic effects of GABA(A) receptor activation. Consistent with these data, we found that physiological concentrations of MG selectively activated GABA(A) receptors in primary neurons. These data indicate that GLO1 increases anxiety by reducing levels of MG, thereby decreasing GABA(A) receptor activation. More broadly, our findings potentially link metabolic state, neuronal inhibitory tone, and behavior. Finally, we demonstrated that pharmacological inhibition of GLO1 reduced anxiety, suggesting that GLO1 is a possible target for the treatment of anxiety disorders.
Life Sciences & Biomedicine Medicine, Research & Experimental Research & Experimental Medicine Science & Technology

Details

Metrics

Logo image